NL188078C - Farmaceutisch preparaat voor de behandeling van hartarrhytmieen en myocardiale aandoeningen. - Google Patents

Farmaceutisch preparaat voor de behandeling van hartarrhytmieen en myocardiale aandoeningen.

Info

Publication number
NL188078C
NL188078C NLAANVRAGE7804567,A NL7804567A NL188078C NL 188078 C NL188078 C NL 188078C NL 7804567 A NL7804567 A NL 7804567A NL 188078 C NL188078 C NL 188078C
Authority
NL
Netherlands
Prior art keywords
arrhytmies
heart
treatment
pharmaceutical preparation
myocardial disorders
Prior art date
Application number
NLAANVRAGE7804567,A
Other languages
English (en)
Other versions
NL188078B (nl
NL7804567A (nl
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IT4918077A external-priority patent/IT1126725B/it
Priority claimed from IT4789878A external-priority patent/IT1155813B/it
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Publication of NL7804567A publication Critical patent/NL7804567A/nl
Publication of NL188078B publication Critical patent/NL188078B/nl
Application granted granted Critical
Publication of NL188078C publication Critical patent/NL188078C/nl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NLAANVRAGE7804567,A 1977-04-29 1978-04-27 Farmaceutisch preparaat voor de behandeling van hartarrhytmieen en myocardiale aandoeningen. NL188078C (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT4918077A IT1126725B (it) 1977-04-29 1977-04-29 Applicazione della acetil-d i-carni tina nella terapia delle affezioni cardiache
IT4789878A IT1155813B (it) 1978-02-03 1978-02-03 Nuova applicazione terapeutica dell'acetil-d i-carnitina e di altri derivati acilati della d- i-carnitina

Publications (3)

Publication Number Publication Date
NL7804567A NL7804567A (nl) 1978-10-31
NL188078B NL188078B (nl) 1991-11-01
NL188078C true NL188078C (nl) 1992-04-01

Family

ID=26329243

Family Applications (1)

Application Number Title Priority Date Filing Date
NLAANVRAGE7804567,A NL188078C (nl) 1977-04-29 1978-04-27 Farmaceutisch preparaat voor de behandeling van hartarrhytmieen en myocardiale aandoeningen.

Country Status (11)

Country Link
US (1) US4194006A (nl)
JP (1) JPS53136523A (nl)
AU (1) AU518617B2 (nl)
BE (1) BE866568A (nl)
CH (1) CH636268A5 (nl)
DE (1) DE2817358A1 (nl)
FR (1) FR2388556A1 (nl)
GB (1) GB1596491A (nl)
IE (1) IE46703B1 (nl)
KE (1) KE3223A (nl)
NL (1) NL188078C (nl)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2414914A1 (fr) * 1978-01-18 1979-08-17 Sigma Tau Ind Farmaceuti Utilisations therapeutiques nouvelles de l'acetyl-1-carnitine et d'autres derives acyles de la 1-carnitine
DE2903579A1 (de) * 1978-02-03 1979-08-09 Sigma Tau Ind Farmaceuti Verwendung von acetylcarnitin und anderen acylderivaten des carnitins zur behandlung der hyperlipoproteinaemie und hyperlimpidaemie sowie arzneimittel
IT1156741B (it) * 1978-05-15 1987-02-04 Sigma Tau Ind Farmaceuti Applicazione terapeutica della carnitina e di alcuni derivati acilati della carnitina nell'emodialisi
IT1156840B (it) * 1978-06-27 1987-02-04 Sigma Tau Ind Farmaceuti Acil derivati della carnitina
IT1206954B (it) * 1979-02-12 1989-05-17 Sigma Tau Ind Farmaceuti Agenti terapeutici a base di un acil derivato della carnitina per la cura di vasculopatie periferiche
US4346107A (en) * 1979-02-12 1982-08-24 Claudio Cavazza Pharmaceutical composition comprising acyl-carnitine for the treatment of impaired cerebral metabolism
IT1116037B (it) * 1979-04-23 1986-02-10 Sigma Tau Ind Farmaceuti Esteri e ammidi di acil carnitine loro procedimenti di preparazione e loro uso terapeutico
IT1120033B (it) * 1979-10-05 1986-03-19 Sigma Tau Ind Farmaceuti Composizione farmaceutica comprendente-carnitina adatta per l'alimentazione parenterale
IT1145362B (it) * 1980-03-06 1986-11-05 Sigma Tau Ind Farmaceuti Classe di acil-derivati della carnitina procedimento per la loro preparazione e loro uso terapeutico
IT1145371B (it) * 1980-05-30 1986-11-05 Sigma Tau Ind Farmaceuti Alcossi-acil carnitine procedimento per la loro preparazione e composizioni farmaceutiche che le contengono
IT1147079B (it) * 1980-05-30 1986-11-19 Sigma Tau Ind Farmacuetiche Ri Esteri di alcossi-acil derivati della carnitina procedimento per la loro preparatione e composizioni farmaceutiche che li contengono
IT1143214B (it) * 1981-07-09 1986-10-22 Sigma Tau Ind Farmaceuti Acil derivato della carnitina quale immunomodulatore
IT1157238B (it) * 1982-10-29 1987-02-11 Sigma Tau Ind Farmaceuti Impiego di 1-carnitina per migliorare i paramenti biochimici e comportamentali dell'eta' senile
IT1150396B (it) * 1982-12-09 1986-12-10 Sigma Tau Ind Farmaceuti Impiego di alcanoil l-carnitine per il trattamento terapeutico di miopa tie e distrofie muscolari
US4537772A (en) * 1984-05-02 1985-08-27 Merck & Co., Inc. Enhancing absorption of drugs from gastrointestinal tract using acylcarnitines
US5545412A (en) * 1985-01-07 1996-08-13 Syntex (U.S.A.) Inc. N-[1, (1-1)-dialkyloxy]-and N-[1, (1-1)-dialkenyloxy]-alk-1-yl-n,n,n-tetrasubstituted ammonium lipids and uses therefor
US4897355A (en) * 1985-01-07 1990-01-30 Syntex (U.S.A.) Inc. N[ω,(ω-1)-dialkyloxy]- and N-[ω,(ω-1)-dialkenyloxy]-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor
CH676930A5 (nl) * 1988-05-26 1991-03-28 Bernardini Attilio
IT1240760B (it) * 1990-02-12 1993-12-17 Sigma Tau Ind Farmaceuti Esteri di acil-l-carnitine con l'acido gamma-idrossibutirrico e composizioni farmaceutiche che li contengono per l'inibizione della degenerazione neuronale e nel trattamento del coma.
IT1240799B (it) * 1990-03-15 1993-12-17 Sigma Tau Ind Farmaceuti Composizioni farmaceutiche contenenti 3-metiltiopropionil l-carnitina ad attivita' sul sistema cardiovascolare.
IT1245869B (it) * 1991-06-05 1994-10-25 Sigma Tau Ind Farmaceuti Impiego di propionil l-carnitina per il recupero del tono muscolare in soggetti immobilizzati
IT1254314B (it) * 1992-03-27 1995-09-14 Sigma Tau Ind Farmaceuti Composizioni farmaceutiche conyenenti l-carnitina e acil- carnitine inassociazione con ace-inibitori per il trattamento di patologie cardiovascolari.
IT1263004B (it) * 1992-10-08 1996-07-23 Sigma Tau Ind Farmaceuti Impiego della l-carnitina e acil l-carnitine nel trattamento a lungo termine di pazienti diabetici non insulino-dipendenti.
US5707971A (en) * 1995-06-07 1998-01-13 Life Resuscitation Technologies, Inc. Modulation of glycolytic ATP production
IT1277897B1 (it) * 1995-08-03 1997-11-12 Mendes Srl Uso della l-carnitina,di suoi derivati e di loro sali farmaceuticamen- te accettabili in combinazione con farmaci antiretrovirali per ridurre
IT1277898B1 (it) * 1995-08-03 1997-11-12 Mendes Srl Uso di amminoacidi basici, di acil derivati di amminoacidi basici e di loro sali farmaceuticamente accettabili per la profilassi di malattie
IT1283951B1 (it) * 1996-03-15 1998-05-07 Mendes Srl Uso della acetil l-carnitina o dei suoi sali farmacologicamente accettabili per il trattamento terapeutico o la profilassi di
IT1291113B1 (it) * 1997-03-20 1998-12-29 Sigma Tau Ind Farmaceuti Composizione nutritiva terapeutica per soggetti affetti da diabete mellito
IT1291127B1 (it) * 1997-04-01 1998-12-29 Sigma Tau Ind Farmaceuti Integratore alimentare per soggetti dediti ad intensa e prolungata attivita' fisica
IT1299197B1 (it) * 1998-06-30 2000-02-29 Sigma Tau Healthscience Spa Composizione ad attivita' antiossidante, antiproliferativa, energetica e atta a migliorare l'utilizzazione metabolica del glucosio.
IT1302125B1 (it) * 1998-08-03 2000-07-31 Sigma Tau Healthscience Spa Composizione ad attivita' antiossidante ed antiproliferativacomprendente una carnitina ed un carotenoide
IT1306173B1 (it) * 1999-07-23 2001-05-30 Sigma Tau Healthscience Spa Composizione per la prevenzione degli affaticamenti muscolari e permigliorare il rendimento energetico muscolare.
US20040229951A1 (en) * 2003-05-15 2004-11-18 Arthur Vanmoor Method of treating fatigue by enhancing the effectiveness of the human immune system
AU2011267186B2 (en) * 2010-06-16 2017-01-19 Alfasigma S.P.A. Acetyl-carnitine for use in a method for increasing neurogenesis in neural tissue
IT202100020729A1 (it) 2021-08-02 2023-02-02 Univ Degli Studi Di Napoli Federico Ii Preparazione combinata per il trattamento della malattia di Pompe

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE719891C (de) * 1938-12-08 1942-04-21 Dr Erich Strack Verfahren zur Herstellung des Methyl- bzw. AEthylesters des acetylierten Carnitins
BE700864A (nl) * 1967-07-03 1967-12-18
US3624887A (en) * 1970-03-02 1971-12-07 Bunker Ramo Pin and socket removal tool
US3968241A (en) * 1972-11-06 1976-07-06 Defelice Stephen L Method of treating cardiac arrhythmias and of improving myocardial contractility and systolic rhythm with carnitive or a pharmaceutically acceptable salt thereof
JPS531812B2 (nl) * 1972-12-07 1978-01-23

Also Published As

Publication number Publication date
AU518617B2 (en) 1981-10-08
KE3223A (en) 1982-09-03
GB1596491A (en) 1981-08-26
IE780643L (en) 1978-10-29
FR2388556B1 (nl) 1981-05-29
NL188078B (nl) 1991-11-01
AU3459878A (en) 1979-10-04
CH636268A5 (it) 1983-05-31
US4194006A (en) 1980-03-18
IE46703B1 (en) 1983-08-24
DE2817358A1 (de) 1978-11-02
NL7804567A (nl) 1978-10-31
JPH0115483B2 (nl) 1989-03-17
DE2817358C2 (nl) 1989-04-27
JPS53136523A (en) 1978-11-29
FR2388556A1 (fr) 1978-11-24
BE866568A (fr) 1978-08-14

Similar Documents

Publication Publication Date Title
NL188078C (nl) Farmaceutisch preparaat voor de behandeling van hartarrhytmieen en myocardiale aandoeningen.
NL7607338A (nl) Werkwijze voor de bereiding van 1,4-dihydro- pyrinederivaten met vaatverwijdende en bloed- drukverlagende activiteit.
NL7900871A (nl) Werkwijze voor de therapeutische behandeling van hyperlipidemie en hyperlipiproteinemie.
NL175991C (nl) Werkwijze voor de bereiding van tetrafluorethaan.
NL7614431A (nl) Werkwijze voor de bereiding van benzyl en aryl- esters van n-fosfonomethylglycinen, van herbicide preparaten en de toepassing daarvan.
NL7607159A (nl) Werkwijzen voor de bereiding en toepassing van fenylazijnzuurderivaten.
NL7608654A (nl) Werkwijze voor de behandeling van titaan- dioxyde pigment.
NL7612200A (nl) Retinezuurderivaat alsmede farmaceutisch preparaat voor de behandeling van acne.
NL189563C (nl) Pyridyl-aminoalkyl-ethers alsmede farmaceutische preparaten daarvan die werkzaam zijn tegen hartritmestoornissen.
NL7811823A (nl) Nieuwe oximen werkwijze voor de bereiding van oxyderen en oximen bevattend therapeutisch preparaat.
NL7811106A (nl) Werkwijze voor de bereiding van moranoline en n-methylmoranoline.
NL187299C (nl) Gevormde farmaceutische doseringseenheid voor het behandelen van hart- en vaatziekten.
NL7802848A (nl) Werkwijze voor de bereiding en toepassing van gesubstitueerde bisbenzimidazolylverbindingen.
NL7607314A (nl) Werkwijze voor de bereiding van haarbehandelings- preparaten.
NL7807890A (nl) Pyranochromoonderivaten, alsmede preparaten voor de be- handeling van allergische aandoeningen, die deze ver- bindingen bevatten.
NL7803493A (nl) Werkwijze voor de bereiding van thermostabiele weefselvormige melkalbuminen.
NL181780C (nl) Farmaceutisch combinatiepreparaat voor de therapie en profylaxe van malaria.
NL7705457A (nl) Werkwijze voor de bereiding van 2.3-dimethylpen- tanal.
NL930042I2 (nl) Werkwijze ter bereiding van een geneesmiddel voor de behandeling van circulatiestoringen en werkwijze ter bereiding van de geneeskrachtige verbindingen.
NL7800001A (nl) Werkwijze voor de bereiding van nieuwe chromoon- derivaten en de toepassing hiervan als genees- middel tegen hartziekten.
NL7800785A (nl) Farmaceutisch en estetisch preparaat, in het bijzonder voor de behandeling van cellulitis.
NL7600047A (nl) Werkwijze voor het bereiden van farmaceutische preparaten voor het behandelen van storingen van de bloedsomloop.
NL7812403A (nl) Farmaceutisch preparaat voor de behandeling van diarree bij de mens.
NL7609028A (nl) Werkwijze voor de bereiding van insecticide en acaricide preparaten.
NL7806894A (nl) Preparaat voor de behandeling van scabies.

Legal Events

Date Code Title Description
A85 Still pending on 85-01-01
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
V4 Discontinued because of reaching the maximum lifetime of a patent

Free format text: 980427